Clinical Report: Can Portal Hypertension Testing Go Non-invasive?
Overview
Non-invasive tests combining liver and spleen stiffness measurements with laboratory findings may aid in identifying portal hypertension and determining the need for further testing.
Background
Portal hypertension is a significant complication of chronic liver disease, leading to serious conditions such as variceal bleeding and hepatic encephalopathy. Accurate assessment of portal hypertension is crucial for effective management and risk stratification. Traditional methods like hepatic venous pressure gradient measurement are invasive and not suitable for routine screening, necessitating the exploration of non-invasive alternatives.
Data Highlights
No numerical data available in the source material.
Key Findings
- Transient elastography is a well-established method for measuring liver stiffness.
- Baveno VII criteria utilize liver stiffness and platelet count to estimate the likelihood of clinically significant portal hypertension (CSPH).
- A liver stiffness measurement of ≤15 kPa with a platelet count of ≥150 × 10^9/L can rule out CSPH.
- Liver stiffness of ≥25 kPa can rule in CSPH.
- Adding spleen stiffness measurement can reduce the indeterminate range of diagnoses from 40-60% to approximately 7-15%.
- AI models combining imaging, laboratory, and clinical data show promise but require further validation.
Clinical Implications
Non-invasive testing methods could streamline the assessment of portal hypertension, making it more accessible for routine clinical practice. The integration of liver and spleen stiffness measurements with laboratory data may enhance diagnostic accuracy and reduce the need for invasive procedures.
Conclusion
The review suggests a stepwise approach to portal hypertension assessment, prioritizing non-invasive methods while retaining invasive measurements for definitive cases. Continued research is necessary to validate these non-invasive strategies in broader clinical settings.
Related Resources & Content
- Journal of Gastroenterology, Established Method for Assessing Hepatic Venous Pressure Gradient in Japan, 2024
- Intensive Care Medicine, Non-invasive intracranial pressure estimation in the intensive care unit: narrative review of methods and clinical applications, 2026
- Critical Care, AI-driven carotid artery compressibility assessment via point-of-care ultrasound for blood pressure estimation in critically ill and post-resuscitation patients: a prospective observational study, 2025
- ECRI Guidelines Trust®, AASLD practice guideline on noninvasive liver disease assessment of portal hypertension
- Cochrane, How accurate is liver and spleen stiffness measured by different elastography techniques in diagnosing clinically significant portal hypertension?
- Baveno VII, Renewing consensus in portal hypertension
- Glaucoma Physician — Home Tonometry Benefits and Limitations
- ECRI Guidelines Trust® - AASLD practice guideline on noninvasive liver disease assessment of portal hypertension.
- How accurate is liver and spleen stiffness measured by different elastography techniques in diagnosing clinically significant portal hypertension? | Cochrane
- Baveno VII – Renewing consensus in portal hypertension - PMC
Based on findings from:
Can Portal Hypertension Testing Go Non-invasive?
The Pathologist, 2026.
https://www.thepathologist.com/issues/2026/articles/august/can-portal-hypertension-testing-go-non-invasive/
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
